Health Care M&A Weekly Deals, The Week Ending February 16, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Bioverativ Inc. License to lentiviral vectors $5 million Oncologie, Inc. Exclusive license to lefitolimod $369 million Lee’s Pharmaceutical Limited Exclusive rights to GCC-4401C N/A Bristol-Myers... Read More »
